Financial intelligence for Asia's healthcare markets
Remember me:

Analysis: A new way to fund healthcare in developing Asia

Susann Roth, senior social development specialist, Asian Development Bank, explains why the ADB is committed to doubling health sector investments by 2020.

A healthy population is the backbone of a strong workforce productivity, which in turn supports inclusive growth and sustainable development. In recent decades, public and private sector investments to drive economic growth and trade have brought tremendous gains to countries in Asia and the Pacific.

But investments in health have lagged behind those in other sectors.

As part of the Sustainable Development Goals, almost every country in the region has committed to universal health coverage (UHC) and providing equitable access to quality care without undue financial hardship.

To deliver on the UHC promise, though, it is essential that countries tackle weak social security systems, focus on persistent pockets of poverty and inequality, enable the private sector to deliver affordable and quality health services and commodities, and reduce out-of-pocket expenditures.

Aging populations foreshadow escalating health care costs in the near future, where both communicable and non-communicable diseases are growing threats. There are also new health risks associated with migration and the effects of climate change.

Unfortunately, the development assistance that in the past had bolstered health financing in Asia and the Pacific region is rapidly declining.

Countries lose eligibility for donor funding as they leave behind their low-income status. Top donors and development partners such as the GAVI Alliance and the Global Fund to Fight AIDS, tuberculosis and malaria are also concentrating on low-income countries.

To make matters even worse, bilateral grant resources and concessional funds are decreasing too.

Asian governments thus struggle to find new ways to mobilize funds to close the huge health financing gap.

Health is part of “social” infrastructure. According to accounting firm PwC, social infrastructure represents around 20% of the region’s total infrastructure investment needs, which are in the trillions of dollars.

To help countries in developing Asia increase health sector funding, ADB is committed to doubling health sector investments to 5% of its total portfolio by 2020. This includes private and public sector loans, and most of this lending will come from ordinary capital resources since many of ADB’s developing member countries have graduated already or will soon be graduating from concessional and grant financing.

Moreover, non-concessional lending is part of the new health sector portfolio being developed by ADB’s Private Sector Operations Department.

Asia’s private health sector is growing rapidly, with many companies aiming to take advantage of emerging markets. The fact that companies and investors are looking at opportunities to invest in the health sector is reflected in ADB’s new health bond, the first ever in this sector issued by a multilateral development bank and launched last March.

The health bond highlights ADB’s commitment to the health sector. It also shows that in today’s increasingly volatile financial environment, investors want low-risk, high-impact investments in health.

The health bond is similar in structure to ADB’s successful water and green bonds, which mobilise funds from financial markets for ordinary capital resources lending in priority sectors. Initially, the health bond will mobilize about US$100 million for health lending in ADB’s sovereign and non-sovereign operations.

In the private sector, the funds raised will contribute to investing in companies that seek high impact on quality, affordability, and accessibility of health services and commodities. ADB has developed an ex-ante due diligence framework to ensure that private sector investments support UHC.

The health bond also targets the public sector, where ADB is working with several lower middle-income countries on strengthening primary health care services, making sure they’re available first of all, and then ready to provide them.

The new funds will be welcomed in countries like India, Kazakhstan, Papua New Guinea or Uzbekistan, where ADB is focused on improving primary and integrated care, health sector management and urban health.

This includes primary and secondary care infrastructure, supporting an enabling environment for public private partnerships, basic medical equipment, digital health infrastructure, staff capacity development, and skills development.

In other words, the health bond opens the door to badly needed long-term financing for health projects. ADB’s developing member countries can expand both public and private spending on health with funding via financial markets.

This is crucial given that the development journey of Asia’s new middle-income countries has not concluded. In fact, it is far from over – especially in health.

Posted on: 07/06/2017 UTC+08:00


News

Beijing-based healthcare service platform Miaoshou Doctor has completed a ¥1.5 billion (US$232 million) Series F round of financing.
Chinese digital technology company, Xisoft Technology, which focuses on hospital operation management, has raised ¥100 million ($15.65 million) in Series A+ financing.
Hearing health company Olive Union has closed a $7M Series B round led by Beyond Next Ventures, Bonds Investment Groups and Japan Policy Finance Corporation.
Long Hill Capital, a venture capital firm in China, has closed on more than $300 million for its third fund on 15 March.
Eluminex Biosciences, an ophthalmic biotechnology company has completed a $50 million Series A financing co-led by Lilly Asia Ventures, GL Ventures (venture capital arm of Hillhouse Capital), and Quan Capital.
TVM Capital Healthcare, a global private equity and growth capital firm focused on emerging markets, has announced two team additions today.
In partnership with VeChain and DNV GL, Renji Hospital, a hospital in China affiliated with the Shanghai Jiaotong University School of Medicine, has launched the world's first blockchain-enabled intelligent tumour treatment centre.
Hong Kong-based BuyHive, a new global sourcing start-up that connects buyers with trusted verified overseas suppliers, has launched a PPE programme to help US companies optimise their post-Covid supply chains.



Analysis

L.E.K. Consulting’s Fabio La Mola tells HealthInvestor Asia about a healthcare market going through major changes – creating significant opportunities for investors in the region.
Edwin Tong, senior minister for health, explains how the Ministry of Health in Singapore is supporting the growth in the number of seniors with Alzheimer's.
Penny Wan, regional vice-president and general manager, Japan and APAC, Amgen, writes about the public health challenge of cardiovascular diseases.
French-based international ophthalmic optics company Essilor has signed Letters of Intent with the Royal Government of Bhutan and the Central Monastic Body to strengthen the country’s vision care infrastructure.
April Chang, country manager at Cigna Singapore, argues that wellness programmes at work can lead to reduced absenteeism, higher productivity and increased morale among employees.
Steven Fang understands how to set up a healthcare company. Not only is he chief executive and founder of ASX-listed oncology company Invitrocue, he was also the founder of Singapore-based Cordlife Group, a healthcare company which provides cord blood and cord lining banking services.
Imagine a world in which you can consult with your doctor via video. She asks for a blood sample, which can be collected and analysed from a device in your home. After that is diagnosed, the prescription is automatically sent to the pharmacy and Uber then picks it up. The time from diagnosis to drugs at your home is only 60 minutes.
The digitisation of health data through blockchain technology is a groundbreaking solution that will empower patients and provide them with better access to healthcare.


Podcasts

HealthInvestor Asia twitter feed










A Rolex Yacht-Master I Ladies Replica watch is basically a person watch that's crafted inside an identical fashion with a well-known maker¡¯s real piece. Purchasing Replica Watches seems as an excellent idea. Anyway,ON perfectcloneshop.com replica Rolex Yacht-Master Ladies watches are affordable, look almost the identical while using real ones and could easily acquired.